Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2014-004590-16-NL
EUCTR2014-004590-16-NL
Active, not recruiting
Not Applicable

18F-Choline PET/CT for patients with primary hyperparathyroidism and negative SPECT/CT - PHPPET study

MC Utrecht0 sitesJanuary 6, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionson familial primary hyperparathyroidismTherapeutic area: Diseases [C] - Hormonal diseases [C19]

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
on familial primary hyperparathyroidism
Sponsor
MC Utrecht
Status
Active, not recruiting
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 6, 2015
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
MC Utrecht

Eligibility Criteria

Inclusion Criteria

  • •\-Patients who have signed informed consent
  • •\-Age \= 18 years
  • •\-Biochemically proven PHP
  • •\-Indication for surgery
  • •\-Negative SPECT/CT
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 8
  • •F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • •\-Pregnancy
  • •\-Patients with MEN syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
18F-Choline PET/CT for patients with primary hyperparathyroidism and negative SPECT/CTprimary hyperparathyroidismoverproduction Parathyroid Hormone10033949
NL-OMON40137niversitair Medisch Centrum Utrecht10
Active, not recruiting
Phase 1
Diagnostic value of 18F-choline PET in patients with indeterminate cytology thyroid nodule : A pilot studyPatient with a thyroid nodule =15mm with indefinite cytology according to the 2008 Bethesda classification (vesicular lesion of undetermined significancefollicular neoplasm or cell Hürthlelesion suspicious for malignancy), and to be operatedMedDRA version: 19.0 Level: HLT Classification code 10043747 Term: Thyroid neoplasms System Organ Class: 100000004860Therapeutic area: Diseases [C] - Hormonal diseases [C19]
EUCTR2015-005017-71-FRCentre François Baclesse135
Not yet recruiting
Not Applicable
se of the PET/CT [18F]-Fluorocholine: Diagnostics and Follow-up of Hepatocellular Carcinomahepatocellular carcinomalivercancer1001981510019818
NL-OMON36749Academisch Medisch Centrum100
Active, not recruiting
Phase 1
Prospective comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the initial work-up of Multiple MyelomaMultiple myelomaMedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2018-003926-10-FRCHU de Bordeaux30
Active, not recruiting
Phase 1
Diagnostic value of 18F-choline PET/CT for the detection of systemic prostate cancer disease. - 2008-CaP-FCHde novo patients with histologically confirmed prostate cancerMedDRA version: 12.0Level: LLTClassification code 10060862Term: Prostate cancer
EUCTR2009-014839-21-FRCIS bio international, member of IBA group150